{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:53:11Z","timestamp":1794243191591,"version":"4.9.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.lana.2025.101110","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T11:13:54Z","timestamp":1746530034000},"page":"101110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Atrial fibrillation in the Americas"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8493-5123","authenticated-orcid":false,"given":"Jason G.","family":"Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Larry R.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Hurwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8739-2099","authenticated-orcid":false,"given":"Carlos A.","family":"Morillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestor","family":"Lopez-Cabanillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.lana.2025.101110_bib1","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ Res"},{"issue":"8A","key":"10.1016\/j.lana.2025.101110_bib2","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.lana.2025.101110_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2188\/jea.15.194","article-title":"Rapid increase in estimated number of persons with atrial fibrillation in Japan: an analysis from national surveys on cardiovascular diseases in 1980, 1990 and 2000","volume":"15","author":"Ohsawa","year":"2005","journal-title":"J Epidemiol"},{"issue":"1","key":"10.1016\/j.lana.2025.101110_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCOUTCOMES.111.962688","article-title":"Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007","volume":"5","author":"Piccini","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1016\/j.lana.2025.101110_bib5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/heart.86.3.284","article-title":"Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database","volume":"86","author":"Majeed","year":"2001","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.lana.2025.101110_bib6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.lana.2025.101110_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ahj.2008.03.010","article-title":"Chronic atrial fibrillation: incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme","volume":"156","author":"Rietbrock","year":"2008","journal-title":"Am Heart J"},{"issue":"17","key":"10.1016\/j.lana.2025.101110_bib8","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","article-title":"Epidemiologic features of chronic atrial fibrillation: the Framingham study","volume":"306","author":"Kannel","year":"1982","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.lana.2025.101110_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.lana.2025.101110_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0002-9149(94)90363-8","article-title":"Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)","volume":"74","author":"Furberg","year":"1994","journal-title":"Am J Cardiol"},{"issue":"18","key":"10.1016\/j.lana.2025.101110_bib11","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.lana.2025.101110_bib12","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.amjcard.2009.07.022","article-title":"Increasing prevalence of atrial fibrillation and flutter in the United States","volume":"104","author":"Naccarelli","year":"2009","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.lana.2025.101110_bib13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/hrt.2006.107573","article-title":"A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland","volume":"93","author":"Murphy","year":"2007","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.lana.2025.101110_bib14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/europace\/eus333","article-title":"Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients","volume":"15","author":"Wilke","year":"2013","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.lana.2025.101110_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae195","article-title":"Global burden of atrial fibrillation\/atrial flutter and its attributable risk factors from 1990 to 2021","volume":"26","author":"Cheng","year":"2024","journal-title":"Europace"},{"issue":"17","key":"10.1016\/j.lana.2025.101110_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030438","article-title":"Global burden of atrial fibrillation and flutter by national income: results from the global burden of disease 2019 database","volume":"12","author":"Ohlrogge","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"16","key":"10.1016\/j.lana.2025.101110_bib17","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jacc.2024.07.014","article-title":"Minimum national prevalence of diagnosed atrial fibrillation inferred from California acute care facilities","volume":"84","author":"Noubiap","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.lana.2025.101110_bib18","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1186\/s12889-022-14403-2","article-title":"Global, regional, and national burden of disease study of atrial fibrillation\/flutter, 1990-2019: results from a global burden of disease study, 2019","volume":"22","author":"Li","year":"2022","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.lana.2025.101110_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24052","article-title":"Global burden of atrial fibrillation\/flutter: trends from 1990 to 2019 and projections until 2044","volume":"10","author":"Ma","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.lana.2025.101110_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ehjqcco\/qcaa093","article-title":"Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs","volume":"8","author":"Burdett","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"1","key":"10.1016\/j.lana.2025.101110_bib21","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1186\/s12913-017-2652-y","article-title":"Cost of illness of atrial fibrillation: a nationwide study of societal impact","volume":"17","author":"Johnsen","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"10.1016\/j.lana.2025.101110_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/europace\/euv248","article-title":"Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France","volume":"18","author":"Cotte","year":"2016","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.lana.2025.101110_bib23","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ijcard.2012.12.093","article-title":"Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century","volume":"167","author":"Ball","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.lana.2025.101110_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/hrt.2002.008748","article-title":"Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK","volume":"90","author":"Stewart","year":"2004","journal-title":"Heart"},{"issue":"15","key":"10.1016\/j.lana.2025.101110_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009024","article-title":"Emergency department visits for atrial fibrillation in the United States: trends in admission rates and economic burden from 2007 to 2014","volume":"7","author":"Rozen","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.lana.2025.101110_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1524-4733.2006.00124.x","article-title":"Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States","volume":"9","author":"Coyne","year":"2006","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.lana.2025.101110_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cjca.2012.03.023","article-title":"The burden of atrial fibrillation on the hospital sector in Canada","volume":"29","author":"O'Reilly","year":"2013","journal-title":"Can J Cardiol"},{"issue":"10","key":"10.1016\/j.lana.2025.101110_bib28","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1185\/030079905X65475","article-title":"Economic burden and co-morbidities of atrial fibrillation in a privately insured population","volume":"21","author":"Wu","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.lana.2025.101110_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3111\/13696990802063425","article-title":"Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective","volume":"11","author":"Lee","year":"2008","journal-title":"J Med Econ"},{"issue":"6","key":"10.1016\/j.lana.2025.101110_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001006","article-title":"Impact of atrial fibrillation on healthcare utilization in the community: the Atherosclerosis Risk in Communities study","volume":"3","author":"Bengtson","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.lana.2025.101110_bib31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.hroo.2022.07.010","article-title":"Healthcare utilization and costs associated with a diagnosis of incident atrial fibrillation","volume":"3","author":"Deshmukh","year":"2022","journal-title":"Heart Rhythm O2"},{"issue":"4","key":"10.1016\/j.lana.2025.101110_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jval.2023.12.015","article-title":"The cost of atrial fibrillation: a systematic review","volume":"27","author":"Buja","year":"2024","journal-title":"Value Health"},{"issue":"9","key":"10.1016\/j.lana.2025.101110_bib33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s12325-009-0066-x","article-title":"Cost of atrial fibrillation in United States managed care organizations","volume":"26","author":"Kim","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.lana.2025.101110_bib34","series-title":"\"Native American.\". Encyclopedia Britannica","author":"Pauls","year":"2025"},{"key":"10.1016\/j.lana.2025.101110_bib35","series-title":"Handbook of South American Indians","author":"Steward","year":"1940"},{"key":"10.1016\/j.lana.2025.101110_bib36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF02858746","article-title":"Native crop diversity in Aridoamerica: Conservation of regional gene pools","volume":"39","author":"Nabhan","year":"1985","journal-title":"Econ Bot"},{"key":"10.1016\/j.lana.2025.101110_bib37","series-title":"Mesoamerica","author":"Wyatt","year":"2010"},{"issue":"11","key":"10.1016\/j.lana.2025.101110_bib38","first-page":"1569","article-title":"Aboriginal health","volume":"155","author":"MacMillan","year":"1996","journal-title":"Can Med Assoc J"},{"issue":"12","key":"10.1016\/j.lana.2025.101110_bib39","article-title":"Mortality profile of the non-Hispanic American Indian or Alaska Native population, 2019","volume":"70","author":"Arias","year":"2021","journal-title":"Natl Vital Stat Rep"},{"issue":"12","key":"10.1016\/j.lana.2025.101110_bib40","first-page":"3","article-title":"Life expectancy of first nations, metis and inuit household populations in Canada","volume":"30","author":"Tjepkema","year":"2019","journal-title":"Health Rep"},{"issue":"19","key":"10.1016\/j.lana.2025.101110_bib41","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.119.042882","article-title":"Incident atrial fibrillation among American Indians in California","volume":"140","author":"Sanchez","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lana.2025.101110_bib42","first-page":"237","article-title":"Racial differences in the prevalence of atrial fibrillation among males","volume":"100","author":"Borzecki","year":"2008","journal-title":"J Natl Med Assoc"},{"issue":"3","key":"10.1016\/j.lana.2025.101110_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121779","article-title":"Cardiovascular disease rates, outcomes, and quality of care in Ontario Metis: a population-based cohort study","volume":"10","author":"Atzema","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lana.2025.101110_bib44","doi-asserted-by":"crossref","first-page":"E156","DOI":"10.9778\/cmajo.20190199","article-title":"Hospital admission for stroke or transient ischemic attack among First Nations people with diabetes in Ontario: a population-based cohort study","volume":"8","author":"Kapral","year":"2020","journal-title":"CMAJ Open"},{"issue":"25","key":"10.1016\/j.lana.2025.101110_bib45","doi-asserted-by":"crossref","first-page":"e948","DOI":"10.1161\/CIR.0000000000000773","article-title":"Cardiovascular health in American Indians and Alaska Natives: a scientific statement from the American Heart Association","volume":"141","author":"Breathett","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.lana.2025.101110_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019581","article-title":"Incident strokes among American Indian individuals with atrial fibrillation","volume":"10","author":"Sanchez","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.lana.2025.101110_bib47","series-title":"Per\u00fa: perfil sociodemogr\u00e1fico","first-page":"214","year":"2017"},{"key":"10.1016\/j.lana.2025.101110_bib48","series-title":"Caracter\u00edsticas de la Poblaci\u00f3n \u2013 Censo 2012","first-page":"103","year":"2012"},{"key":"10.1016\/j.lana.2025.101110_bib49","series-title":"S\u00edntesis de Resultados Censo 2017","first-page":"16","year":"2017"},{"key":"10.1016\/j.lana.2025.101110_bib50","series-title":"Censo Demogr\u00e1fico 2022: Identifica\u00e7\u00e3o \u00e9tnico-racial da popula\u00e7\u00e3o, por sexo e idade","year":"2022"},{"key":"10.1016\/j.lana.2025.101110_bib51","series-title":"Departamento Administrativo Nacional de Estad\u00edstica","year":"2018"},{"key":"10.1016\/j.lana.2025.101110_bib52","series-title":"Poblaci\u00f3n ind\u00edgena o descendiente de pueblos ind\u00edgenas u originarios","year":"2022"},{"key":"10.1016\/j.lana.2025.101110_bib53","series-title":"Instituto Nacional de Estad\u00edstica y Censos","year":"2023"},{"key":"10.1016\/j.lana.2025.101110_bib54","series-title":"Instituto Nacional de Estad\u00edstica","year":"2018"},{"key":"10.1016\/j.lana.2025.101110_bib55","series-title":"Bureau of Statistics, Guyana","year":"2012"},{"key":"10.1016\/j.lana.2025.101110_bib56","series-title":"Poblaci\u00f3n por sexo y principal ascendencia \u00e9tnico racial, seg\u00fan departamento","year":"2011"},{"key":"10.1016\/j.lana.2025.101110_bib57","series-title":"Demografische en Sociale Karakteristieken en Migratie","year":"2019"},{"issue":"5","key":"10.1016\/j.lana.2025.101110_bib58","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40520-017-0810-z","article-title":"Low prevalence of atrial fibrillation in Amerindians: a population-based study in frequent fish consumers living in rural coastal Ecuador (The Atahualpa Project)","volume":"30","author":"Del Brutto","year":"2018","journal-title":"Aging Clin Exp Res"},{"issue":"12 Suppl","key":"10.1016\/j.lana.2025.101110_bib60","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.cjco.2021.09.010","article-title":"Historical and continued colonial impacts on heart health of indigenous peoples in Canada: what's reconciliation got to do with it?","volume":"3","author":"Schultz","year":"2021","journal-title":"CJC Open"},{"issue":"5","key":"10.1016\/j.lana.2025.101110_bib61","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cjco.2021.01.003","article-title":"Surveillance for outcomes selected as atrial fibrillation quality indicators in Canada: 10-year trends in stroke, major bleeding, and heart failure","volume":"3","author":"Wilton","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.lana.2025.101110_bib63","article-title":"Prevalance, management, and comorbidities of adults with atrial fibrillation in the United States, 2019 to 2023","volume":"3","author":"Oltman","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.lana.2025.101110_bib64","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s11239-023-02855-1","article-title":"Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation","volume":"56","author":"Atwater","year":"2023","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.lana.2025.101110_bib65","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.hrthm.2017.10.019","article-title":"Urban-rural differences in mortality for atrial fibrillation hospitalizations in the United States","volume":"15","author":"O'Neal","year":"2018","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.lana.2025.101110_bib66","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.hrthm.2015.03.031","article-title":"Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation","volume":"12","author":"Bhave","year":"2015","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.lana.2025.101110_bib67","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0247","article-title":"Racial\/ethnic and socioeconomic disparities in management of incident paroxysmal atrial fibrillation","volume":"4","author":"Eberly","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lana.2025.101110_bib68","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/CEOR.S402344","article-title":"Race and ethnic and sex differences in rhythm control treatment of incident atrial fibrillation","volume":"15","author":"Jackson Ii","year":"2023","journal-title":"Clinicoecon Outcomes Res"},{"issue":"12","key":"10.1016\/j.lana.2025.101110_bib69","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/jamacardio.2018.3945","article-title":"Association of race\/ethnicity with oral anticoagulant use in patients with atrial fibrillation: findings from the outcomes registry for better informed treatment of atrial fibrillation II","volume":"3","author":"Essien","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.lana.2025.101110_bib70","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40256-021-00502-9","article-title":"Direct oral anticoagulants and warfarin for atrial fibrillation treatment: rural and urban trends in medicare beneficiaries","volume":"22","author":"Norby","year":"2022","journal-title":"Am J Cardiovasc Drugs"},{"issue":"5","key":"10.1016\/j.lana.2025.101110_bib71","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027211","article-title":"Sex differences in oral anticoagulation therapy in patients hospitalized with atrial fibrillation: a nationwide cohort study","volume":"12","author":"Lee","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.lana.2025.101110_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14107","article-title":"Temporal trends of gender disparities in oral anticoagulant use in patients with atrial fibrillation","volume":"54","author":"Teppo","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.lana.2025.101110_bib73","series-title":"United Nations Department of Economic and Social Affairs PD","year":"2022"},{"issue":"1","key":"10.1016\/j.lana.2025.101110_bib74","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.hroo.2024.11.010","article-title":"Current state of arrhythmia care in Latin America: a statement from the Latin American Heart Rhythm Society","volume":"6","author":"Rojel","year":"2025","journal-title":"Heart Rhythm O2"},{"issue":"13","key":"10.1016\/j.lana.2025.101110_bib75","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jacc.2018.07.037","article-title":"Edoxaban versus warfarin in Latin American patients with atrial fibrillation: the ENGAGE AF-TIMI 48 trial","volume":"72","author":"Corbal\u00e1n","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.lana.2025.101110_bib76","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American heart association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.lana.2025.101110_bib77","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.cjca.2020.09.001","article-title":"The 2020 Canadian cardiovascular society\/Canadian heart rhythm society comprehensive guidelines for the management of atrial fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol"},{"issue":"36","key":"10.1016\/j.lana.2025.101110_bib78","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.lana.2025.101110_bib79","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1160\/TH17-08-0555","article-title":"Regional differences in antithrombotic treatment for atrial fibrillation: insights from the GLORIA-AF phase II registry","volume":"117","author":"Mazurek","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lana.2025.101110_bib80","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/IJGM.S62819","article-title":"Burden of disease from atrial fibrillation in adults from seven countries in Latin America","volume":"7","author":"Cubillos","year":"2014","journal-title":"Int J Gen Med"},{"issue":"3","key":"10.1016\/j.lana.2025.101110_bib81","doi-asserted-by":"crossref","first-page":"426","DOI":"10.36660\/abc.20190873","article-title":"Atrial fibrillation diagnosis using ECG records and self-report in the community: cross-sectional analysis from ELSA-brasil","volume":"117","author":"Santos","year":"2021","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"10.1016\/j.lana.2025.101110_bib82","first-page":"538","article-title":"Carga econ\u00f3mica de la fibrilaci\u00f3n auricular en Colombia","volume":"27","author":"Mendoza","year":"2020","journal-title":"Rev Colomb Cardiol"},{"issue":"1","key":"10.1016\/j.lana.2025.101110_bib83","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5334\/gh.767","article-title":"Anticoagulation therapy by age and embolic risk for nonvalvular atrial fibrillation in Mexico, an upper-middle-income country: the CARMEN-AF registry","volume":"15","author":"M\u00e1rquez","year":"2020","journal-title":"Global heart"},{"issue":"6","key":"10.1016\/j.lana.2025.101110_bib84","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1590\/1516-3180.2015.0222110716","article-title":"Targeting stroke risk and improving outcomes in patients with atrial fibrillation in Latin America","volume":"134","author":"Stambler","year":"2016","journal-title":"Sao Paulo Med J"},{"issue":"5","key":"10.1016\/j.lana.2025.101110_bib85","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/clc.23176","article-title":"Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: insights from the GARFIELD-AF registry","volume":"42","author":"Jerjes-Sanchez","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.lana.2025.101110_bib86","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/205013","article-title":"Left atrial appendage: physiology, pathology, and role as a therapeutic target","volume":"2015","author":"Regazzoli","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.lana.2025.101110_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132098","article-title":"Trends in percutaneous left atrial appendage occlusion and 1-year mortality 2013-2021: a nationwide observational study","volume":"408","author":"Madsen","year":"2024","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.lana.2025.101110_bib88","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.lana.2025.101110_bib89","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.lana.2025.101110_bib90","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/europace\/euab029","article-title":"Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation","volume":"23","author":"Kuniss","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.lana.2025.101110_bib91","article-title":"Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - observations from the GARFIELD-AF registry","volume":"49","author":"Pope","year":"2023","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"3","key":"10.1016\/j.lana.2025.101110_bib92","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.hroo.2022.12.005","article-title":"Contemporary trends in cardiac electrophysiology procedures in the United States, and impact of a global pandemic","volume":"4","author":"Scott","year":"2023","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.lana.2025.101110_bib93","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.amjcard.2023.06.023","article-title":"Variations in atrial fibrillation ablation use and charges in a modern cohort of medicare beneficiaries","volume":"202","author":"Aglan","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lana.2025.101110_bib94","doi-asserted-by":"crossref","DOI":"10.1007\/s10840-024-01942-4","article-title":"The second Latin American catheter ablation registry (\u201cII LAHRS EP registry\u201d)","author":"Rojel Martinez","year":"2024","journal-title":"J Interv Card Electrophysiol"},{"issue":"10","key":"10.1016\/j.lana.2025.101110_bib95","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.hroo.2024.06.010","article-title":"Global voices on atrial fibrillation management: Brazil","volume":"5","author":"Santos","year":"2024","journal-title":"Heart Rhythm O2"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X25001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X25001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T22:52:36Z","timestamp":1752619956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X25001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":93,"alternative-id":["S2667193X25001206"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2025.101110","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial fibrillation in the Americas","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2025.101110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101110"}}